Microbiological and Clinical Aspects of Actinomyces Infections
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 37312
Special Issue Editors
Interests: clinical microbiology; anaerobes; oral microbiology; epidemiology; Actinomyces spp.; Bacteroides spp.; Clostridium difficile; MALDI-TOF MS; molecular biology; medicine
Interests: epidemiology; clinical microbiology; resistance trends; UTIs, antimicrobial stewardship; knowledge-attitude-practice (KAP); novel antimicrobials; drug design; anaerobes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Actinomyces species are anaerobic, non-spore-forming Gram-positive rods that are important saprophytic constituents of the normal microbiota of humans, with highest numbers in the oropharynx (oral mucosa, gingival crevices, periodontal pockets, tonsillar crypts and dental plaques). Actinomyces species are considered as low-grade pathogens, without possessing ’classical’ virulence factors, therefore they can only cause disease if normal mucosal barriers have been disrupted or predisposing factors are present. Actinomyces infections (actinomycoses) are considered to be rare, however, due to the slow-growing and fastidious nature of these microorganisms, many Institutions do not have the capabilities or interest for their full diagnostic workup, therefore their true prevalence may be underestimated. Additonally, diagnosis of actinomycosis may be difficult as the clinical presentation of symptoms and signs can mimic other pathologies. Although antibiotic therapy is the mainstay of treating Actinomyces infections, surgical interventions as adjunctive therapy should also be considered. MALDI-TOF MS has allowed for the correct and precise identification of anaerobes in a clinically-relevant time frame, compared to conventional, biochemical methods.
The purpose of this Special Issue is to enrich the existing literature regarding this neglected pathogen, therefore manuscripts including but not limited to the following topics are welcome: vaulable case reports and novel results on the epidemiology, diagnostics, clinical features and therapy of actinomycoses, in addition to experimental findings on the virulence factors and resistace determinants of Actinomyces spp.
Prof. Dr. Edit Urbán
Dr. Márió Gajdács
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- actinomyces spp.
- actinomycosis
- anaerobes
- cervicofacial infections
- thoracic infections
- abdominal infections
- pelvic infections
- dentistry
- surgery
- antibiotic therapy
- MALDI-TOF MS
- clinical microbiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.